Julián Solís-García Del Pozo

12PUBLICATIONS
16CO-AUTHORS
Sub-acute careDisease surveillanceCancer therapy (excl. chemotherapy and radiation therapy)Instrumental methods (excl. immunological and bioassay methods)Epidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 25, 2024
Frailty as a Risk Factor for Depression after COVID-19 Hospital Admission.

Isabel María Soler-Moratalla, Sergio Salmerón, Silvia Lozoya-Moreno

|Jun 23, 2022
Global trends of dalbavancin: A bibliometric analysis.

Nuria Monteagudo-Martínez, Julián Solís García Del Pozo, Ichiro Ikuta

|May 13, 2022
Are there differences between ceftolozane/tazobactam and ceftazidime/avibactam in treating patients with complicated abdominal infections? Evidence from clinical trials.

M C Avilés Martínez, J J Alfaro Martínez, J J Blanch Sancho

|Apr 12, 2022
Common Laboratory Parameters Are Useful for Screening for Alcohol Use Disorder: Designing a Predictive Model Using Machine Learning.

Juana Pinar-Sanchez, Pablo Bermejo López, Julián Solís García Del Pozo

|Sep 28, 2021
Current Evidence on the Antimicrobial Treatment and Chemoprophylaxis of Human Leptospirosis: A Meta-Analysis.

Marta Guzmán Pérez, José Javier Blanch Sancho, Juan Carlos Segura Luque

|May 27, 2021
Systematic review and meta-analysis on the safety of dalbavancin.

N Monteagudo-Martínez, J Solís-García Del Pozo, Ichiro Ikuta

Pageof 2